Get started
Senseonics Holdings, Inc.Senseonics Holdings, Inc.Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

SENS trade ideas

Senseonics Reversing. SENSEither a Wave 4 WXY pattern or a more general turnaround. Both scenarios are bearish. Note divergences and dropping momentum also. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets going down are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
AMEX:SENSShort
by Rykin_Capital
1
SENS Continues Holding LevelsPulled SENS back up again after a few weeks and see that it's still holding the same fib and trendline levels as it was when we first drew out the fib retracement. It's also now holding the 50DMA consistently as it steadily rises. For some context, this company develops and commercializes continuous glucose monitoring systems for diabetes patients. Senseonics offers the Eversense and Eversense XL products in its lineup. These are implantable CGM systems for measuring glucose levels with an under-skin sensor, and a removable and rechargeable smart transmitter. Sensonics also offers an app for real-time diabetes metrics monitoring. Other Highlights: - HC Wainwright $6 target and buy rating last month - Collab with University Hospitals Accountable Care Organization - Raised $50 million in gross proceeds through completion of At-the-Market equity offering program last quarter. Proceeds earmarked "primarily for debt service" -Year-To-Date up over 320% so far
AMEX:SENS
by PennyStocks101
$SENS What's Next?Noted in the trend band, $SENS has floated within its average for the last 3 months, with a small upward move from its initial 180 day CGM submission to the FDA. Although $SENS has report net loss, it is expected from a company within its product growth cycle. Additionally, new employees were hired to speed the R & D of its programming and engineering. New Employees were paid in equity shares, and lockup is until milestones are achieved, which has contributed to its expenses. So, whats next? The 180 CGM sensor is still in play as FDA has it on the table for review. Considering the extent of healthcare networks added to the market, another potential for $SENS is a merger or partnership from big pharma.
AMEX:SENSLong
by mrtnquint
1
SENS Back Testing The 382 Fib Watching To Act As SupportThe thing about SENS is that it's been a company crushing it in 2021. When it was first discussed this year it was still trading below $1. Despite recent volatility, it's up significantly year-to-date. I think volume remains steady but definitely on the lower end of the range. But good data from the last presentation on its PROMISE study seems to have sparked more attention. "The data evaluating the safety and accuracy of the next generation Eversense system was presented by Satish Garg , MD, Professor of Medicine at the Barbara Davis Center of the University of Colorado, Denver , and the PROMISE study group Principal Investigator (PI). The Company presented previously released information demonstrating performance matching that of the current 90-day sensor available in the United States , with reduced calibration, down to one per day, with duration extended to 180 days. Accuracy measurements discussed in the oral presentation include a mean absolute relative difference (MARD) of 9.1% for the primary sensor and confirmed hypoglycemia alert detection rates at 60 mg/dL of 87% and at 70 mg/dL of 93%. For the subset of 43 modified sensors (referred to as the SBA sensor), the MARD was 8.5% and the confirmed hypo alert detection rates at 60 mg/dL and 70 mg/dL were 90% and 94%, respectively." Another area of potential support/resistance is just below the 382 fib line (in yellow), which has held so far this week. It was resistance a few weeks back. With SENS failing almost right at the 236 Fib line, technical traders are liking monitoring these levels closely. Latest on SENS: Best Penny Stocks to Buy Right Now? 7 Small-Caps For Your Morning List
AMEX:SENS
by PennyStocks101
SENS BUY/LONG NOW READY! 2.95 TO 6.75 BY SEPT 2021TICKER CODE: SENS Company Name: SENSEONICS HOLDINGS, INC. Industry: ELECTRONIC TECHNOLOGY. ELECTRONIC COMPONENTS Position Proposed: BUY/LONG Entry: BUY READY (2.85-2.95) 1st Partial Take Profit: 5.67 (JUNE 2022-AUG 2022) 2nd Partial Take Profit: 6.75 (OCT 2022-DEC 2022) Potential Full Take Proft: 9.93 (Mid YR 2023- Early 2024) Stop Loss: 1.65-1.70 Technical Analysis 1. Speaker Phone Formation would Indicate a Potential BUY to Take Profit Levels. 2. Inverse Head & Shoulders forming indicating a Potential BUY to Take Profit Levels. 3. Flagpole + Falling Wedge Formed and Done Retracement indicating a Potential BUY to Take Profit Levels. 4. Fibonacci levels indicate a Retracement at Golden Zone (0.786) to Levels 5.67, 6.75, and FInally 9.93 in the Following Years.
AMEX:SENSLong
by traderprosignals
2
$SENS can rise in the next daysContextual immersion trading strategy idea. Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2.91; stop-loss — $2.52. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
AMEX:SENSLong
by KozakHlib
1
$SENS Cheapie w Huge Volume and Large move potential $SENS Broke out of not one but 2 high tight flags, might not pullback but if it does we would find this attractive around the 2.50 mark. It closed in the cypher window in the 1 hour tf, which can lead to pullback, I do not care for this pattern in low time frame but it is possible they try to shake week hands on this before they run it up. Worth setting price alert for at minimum. Thanks for looking guys and good luck this week. Some DD for you if you have any interest in the name = www.zacks.com app.koyfin.com
AMEX:SENSLong
by Hiddenharmonicstrading
5
SENS - Coming back to its senses! 🙌-Shares of Senseonics (NYSEMKT:SENS) are on the march in Friday’s pre-market action stock after the medtech firm reported positive test results for its glucose-monitoring system. SENS stock was up more than 30% at 8:30 a.m. Eastern. -SENS stock closed Thursday at $2.05 a share after surging over the past six month. The shares used to trade deep in penny stock territory, below 50 cents through most of 2020. -Senseonics is focused on developing and commercializing long-term implantable continuous glucose monitoring systems, or CGMs, for patients with diabetes. It is novel in that it can be implanted and then provide data for up to six months. -Big move comes after the firm said study results for both a primary and secondary glucose sensor — or an SBA sensor — showed promising preliminary results. The study sought to evaluate Senseonics’ Eversense CGM System in patients with diabetes, testing them over a 180-day period. The study is the basis of the pre-market application submissions to the U.S. Food and Drug Administration and to European regulators for a CE mark, the company said.
AMEX:SENSLong
by caldooninvestment
16